Other ingredients
Gelatin; Glycerin; Water; Purified
Image: NIH Office of Dietary Supplements, Dietary Supplement Label Database — No separate image reuse license stated
FINAFLEX
CLA
Softgel Capsule
Serving size1 Softgel(s)
Servings per containerNot listed
Package90 Softgel(s)
Data retrievedJul 28, 2026
Supplement Facts
Serving size 1 Softgel(s)
Total Fat1 g2% DV
Conjugated Linoleic Acid1000 mgDV not established
Label directions
Suggested use: As a dietary supplement take 1 serving (1 softgel) of CLA daily with meals.
Label warnings
Allergen warning: Produced in a facility that processes milk eggs soybeans wheat shellfish fish oil tree nuts sesame and peanuts. Warning: Keep out of reach of children. Do not use if pregnant or nursing. Consult a doctor or medical authority before use if you have a medical condition a family history of health problems or if you take other medicines or supplements. Product is intended for healthy adults over 18. Do not exceed serving size. Stop use immediately if you have a bad reaction. Do not use more than 8 weeks. Stop taking 2 weeks before surgery. Consumer accepts all liability if product used inconsistent with labeling guidelines. California Prop 65 warning: Lead; Cancer and reproductive harm www.P65Warnings.ca.gov
Identity and label version
NIH label record333640
Entered into NIH DSLDJul 24, 2025
UPC / GTIN00810020720143
Manufacturer / distributor on labelFINAFLEX
Market statusOn market in the source data
“Entered into NIH DSLD” is the database entry date for this label record. It is not a manufacturer launch date or a label effective date.
NIH label history (1)
Current labelNIH record 333640Entered Jul 24, 2025
Total Fat1 g
Conjugated Linoleic Acid1000 mg
Label warning: Allergen warning: Produced in a facility that processes milk eggs soybeans wheat shellfish fish oil tree nuts sesame and peanuts. Warning: Keep out of reach of children. Do not use if pregnant or nursing. Consult a doctor or medical authority before use if you have a medical condition a family history of health problems or if you take other medicines or supplements. Product is intended for healthy adults over 18. Do not exceed serving size. Stop use immediately if you have a bad reaction. Do not use more than 8 weeks. Stop taking 2 weeks before surgery. Consumer accepts all liability if product used inconsistent with labeling guidelines. California Prop 65 warning: Lead; Cancer and reproductive harm www.P65Warnings.ca.gov
Sources and traceability
- NIH Dietary Supplement Label DatabaseData retrieved Jul 28, 2026Open source ↗
More from FINAFLEX
Data comes from product labels or official public sources. It does not mean Safmira, NIH, or FDA approves, certifies, or recommends this product. Label amounts are not laboratory measurements.